Abstract
2345
Introduction: Radiopharmaceutical therapies (RPTs) with Lutetium-177 (177Lu) and Actinium-225 (225Ac) labelled
pharmaceuticals have shown very promising patient responses for malignancies such as prostate cancer and
neuroendocrine tumors. An improved understanding of the dose deposition at the cellular level is required
to better comprehend the healing mechanism of these therapies. Simulating 3D layers of thousands of cells
to replicate human tissue with a Monte Carlo simulation toolkit such as GATE would be architecturally
challenging, computationally intensive, and require years of current technology hardware use. Therefore,
we have developed a novel kernel-based generation method to simulate cellular nucleus doses in LnCaP
(human prostate cancer) cells from activities of 177Lu or 225Ac. The created absorbed dose kernel, which
describes the impact of activity in one cell to the surrounding cells in the tissue, could be directly applied
to autoradiography images to gain a better understanding of cellular dosimetry and radiobiology in RPTs.
Methods: A spherical LnCaP prostate cancer cell placed in water was modelled using GATE version 9.0. The cell
model included the nucleus, nuclear membrane, cytoplasm, and cellular membrane. Water density was
assumed for all cell parts. The cell radius was 13.498 μm, based on human LnCaP cells. Using a bash
script, the cell nuclei (without the other cell parts) were replicated in the X and Y directions every 13.498
μm to create a two-dimensional layer of cell nuclei that was 31 x 31 and 16 x 16 cells in size for 177Lu and
225Ac respectively. A complete cell including the cytoplasm, membrane, or extracellular region of the
original cell was placed at the bottom left point of the grid. Each source region (the cytoplasm, membrane,
or extracellular region) in the bottom left cell was filled with a homogeneous activity distribution of either
177Lu or 225Ac. Simulations were performed separately for the three regions. In each source region, 2x108
and 4x105 primaries were simulated for 177Lu and 225Ac, respectively. These simulated primaries were
selected such that the uncertainty in deposited energy was less than 10% in each pixel. To measure the total
energy deposited in each nucleus, the GATE “Edep” actor was attached to each nucleus in the grid. The
total deposited energy was then converted into a specific S-value representing the dose per decay to the
nuclei from activity placed in each different source region. Using Python, the S-values were combined to
create a grid matching the cell distribution in GATE, creating one quadrant of a dose kernel with the source
activity located at the bottom left corner. This quadrant was flipped and rotated appropriately to replicate
the other three quadrants and create a 2D absorbed dose kernel describing the impact of activity in the
center cell’s membrane, cytoplasm, or extracellular region to the surrounding cells.
Results: Figure 1 shows a profile through the center of the 2D dose kernels for 177Lu and 225Ac with activity placed
at the center of the grid in each different source region of the cell. Internalization assays can be used to
scale the contribution of each of the kernels (i.e. for each source region) appropriately to match the cell
distribution of a radiopharmaceutical of interest.
Conclusions: We have derived dose kernels representing the doses per decay absorbed by LnCaP cell nuclei from activity
of 177Lu as well as 225Ac labelled radiopharmaceuticals placed within the cytoplasm, membrane, or
extracellular region of another cell in the vicinity. These kernels can be convolved with a cellular activity
distribution of interest to generate cellular dose maps for 177Lu or 225Ac labelled pharmaceuticals. The
activity distributions can be measured using autoradiography techniques. We hypothesize that these kernels
can be used to find correlations between cellular absorbed doses and cellular biological responses to
therapy.